SEC Form D · filed August 1, 2022
Mira1a Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Brad Kroenig · Baltimore, MDDirectorJude Uzonwanne · Baltimore, MDExecChris Chapman, Md · Baltimore, MDDirectorAdam Kaplin, Md, Phd · Baltimore, MDExecTalhia Tuck, Jd · Baltimore, MDDirectorHugh Mccoll Iii · Baltimore, MDDirectorJosh Silverman · Baltimore, MDDirectorDave Vorhoff · Baltimore, MDDirectorJames Mcnulty, Cpa · Baltimore, MDExecPaul Rivard, Esq · Baltimore, MDExecJeff Pavell · Sarasota, FLDirectorEric Weisblum · Sarasota, FLExecBrian D. Edgar · VANCOUVER, British Columbia, CanadaDirectorDarren E. Klinck · VANCOUVER, British Columbia, CanadaExecWayne Linsley · Sarasota, FLDirectorTimothy T. Barry · VANCOUVER, British Columbia, CanadaDirectorChristian J. Milau · VANCOUVER, British Columbia, CanadaDirectorVera W. Kobalia · VANCOUVER, British Columbia, CanadaExecG. W. Carson · VANCOUVER, British Columbia, CanadaExecKevin Munoz · Sarasota, FLDirectorJohn Banta · McLean, VAExecShannon K. Jagodinski · George Town, Grand Cayman, Cayman IslandsExecWhite Post Investments, LP · San Antonio, TXDirectorWhite Post Opportunity GP, LLC · San Antonio, TXDirectorChristopher Zarou · Garden City, NYExecSimon Cawdery · George Town, Cayman IslandsDirectorJeff Fox · Little Rock, ARDirectorNicholas Tuosto · Santa Monica, CADirectorPhilip Sanderson · Santa Monica, CADirectorDarin Myman · New Brunswick, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗